) % Revenue from sales and service 1,788.5 2,025.3 1,187.1 (236.8) (11.7) 601.4 50.7 Cost of sales and service 1,499.5 1,686.8 998.7 (187.3) (11.1) 500.8 50.1 Selling and distribution expenses 73.7 78.7 52.0
sales staffs, advertising media fee for product promotion, distribution fee paid to Zuellig Pharma Ltd. under the Distribution Agreement and compensation for distribution of company’ s products in the
0.00 12.21 N/A 6.95% 0.00% Revenues from reduction of defaulted interest under the Court’s order 16.66 0.00 16.66 N/A 9.48% 0.00% Distribution costs (24.14 ) (26.13 ) (1.99 ) 7.62% (13.74%) (8.83
) % Revenue from sales and service 1,788.5 2,025.3 1,187.1 (236.8) (11.7) 601.4 50.7 Cost of sales and service 1,499.5 1,686.8 998.7 (187.3) (11.1) 500.8 50.1 Selling and distribution expenses 73.7 78.7 52.0
trustee, under Clause 20; (13) the trust’s disclosure of information, under Clause 21; (14) the distribution to the unit holders, under Clause 22; (15) the proposal for resolution and the general meeting of
allocation) และสอดคล้องกับผลการประเมินระดับความเสี่ยงที่ลูกค้ายอมรับได้ และเป้าหมายในการลงทุนของลูกค้า (ค) การดำเนินการเพื่อประโยชน์ในการลงทุนตามแผนจัดสรรการลงทุน
strategy Calendar year performance and benchmarks over the past five years (% per annum) Fund Information Registration Date Class Launch Date Dividend Distribution Policy Fund Duration List of Fund Managers
five years (% per annum) Fund Information Registration Date Class Launch Date Dividend Distribution Policy Fund Duration List of Fund Managers Past performance at specific periods (% per annum
Investment policy and strategy Calendar year performance and benchmarks over the past five years (% per annum) Fund Information Registration Date Class Launch Date Dividend Distribution Policy Fund Duration
Explanation Investment policy and strategy Calendar year performance and benchmarks over the past five years (% per annum) Fund Information Registration Date Class Launch Date Dividend Distribution Policy Fund